Drug Profile


Alternative Names: INS 50589 Antiplatelet; INS 50589 Cardiovascular; INS-50589

Latest Information Update: 16 Dec 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inspire Pharmaceuticals
  • Class Antiplatelets; Small molecules
  • Mechanism of Action Purinergic P2 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Thrombosis

Most Recent Events

  • 16 Dec 2008 Discontinued - Phase-II for Thrombosis in USA (IV)
  • 11 Aug 2006 Suspended - Phase-II for Thrombosis in USA (IV-infusion)
  • 28 Apr 2006 Phase-II clinical trials in Thrombosis in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top